<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01458015</url>
  </required_header>
  <id_info>
    <org_study_id>TapOxy01</org_study_id>
    <nct_id>NCT01458015</nct_id>
  </id_info>
  <brief_title>Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain</brief_title>
  <official_title>Phase 4 Study of Tapentadol vs Oxycodone in Neuropathic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e.
      reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain
      signs and symptoms in comparison to oxycodone.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>QST parameters on mechanical and thermal thresholds (detailed below)</measure>
    <time_frame>day 0 (baseline) and day 78 (10 weeks)</time_frame>
    <description>change from baseline in mechanical and thermal pain thresholds and sensitivity measured by QST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mechanical pain threshold (MPT)</measure>
    <time_frame>day 0 (baseline) and day 78 (10 weeks)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>mechanical pain sensitivity (MPS)</measure>
    <time_frame>day 0 (baseline) and day 78 (10 weeks)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>dynamic mechanicl allodynia (DMA)</measure>
    <time_frame>day 0 (baseline) and day 78 (10 weeks)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>wind-up ratio (WUR)</measure>
    <time_frame>day 0 (baseline) and day 78 (10 weeks)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Peripheral Neuropathy</condition>
  <arm_group>
    <arm_group_label>oxycodone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>tapentadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tapentadol, oxycodone</intervention_name>
    <description>tapentadol pr 100-500 mg oxycodone cr 20-120mg</description>
    <arm_group_label>oxycodone</arm_group_label>
    <arm_group_label>tapentadol</arm_group_label>
    <other_name>Palexia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  thermal or mechanical hyperalgesia

          -  chronic neuropathic pain (NRS =&gt; 6)

        Exclusion Criteria:

          -  non-specific
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Baron, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Unit of Neuropathic Pain Research and Therapy, Department of Neurology, University Clinic Kiel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division for Neurological Pain Research and Therapy</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2011</study_first_submitted>
  <study_first_submitted_qc>October 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2011</study_first_posted>
  <last_update_submitted>March 25, 2014</last_update_submitted>
  <last_update_submitted_qc>March 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Ralf Baron</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>QST</keyword>
  <keyword>neuropathic pain</keyword>
  <keyword>tapentadol pr</keyword>
  <keyword>oxycodone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

